James Aden

Dr. James Aden

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2006 in Cancer Research
Verified
Journal Article
Closed access
PDF file
XWXia Wang
Xia Wang
WJWei Ju
Wei Ju
JRJordan Renouard
Jordan Renouard
JAJames Aden
James Aden
SBSteven Belinsky
Steven Belinsky
YLYong Lin
Yong Lin
Nuclear factor-κB (NF-κB), a survival signal induced by tumor necrosis factor (TNF), contributes substantially to the resistance to TNF-induced cell death. Previous studies suggest that heat shock protein 90 (Hsp90) regulates the stability and function of receptor-interaction proteins (RIP) and IκB kinase β (IKKβ), the key components of the TNF-induced NF-κB activation pathway. In this study, we showed that the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17AAG) was synergistic with TNF to induce apoptotic cell death in a panel of lung tumor-derived cell lines. Treatment with 17AAG caused degradation of RIP and IKKβ that, in turn, blocked TNF-induced NF-κB activation and antiapoptotic gene expression. The synergistic cytotoxicity was detected only when TNF treatment followed 17AAG preexposure. Importantly, the potentiation of cell death was abolished in NF-κB-disabled cells that express a nondegradable IκBα mutant (IκBαAA). These results suggest that the cytotoxicity seen with 17AAG and TNF treatment results from blocking TNF-induced NF-κB activation. The other components of the TNF receptor I signaling cascade were not altered, whereas TNF-induced c-Jun NH2-terminal kinase activation and apoptosis were potentiated. A similar synergism for inducing apoptosis was also observed in 17AAG-treated and TNF-related apoptosis-inducing ligand (TRAIL)–treated cancer cells. Our results suggest that NF-κB plays a key role in the resistance of lung cancer cells to TNF and TRAIL and that disabling this survival signal with 17AAG followed by TNF or TRAIL treatment could be an effective new therapeutic strategy for lung cancer. (Cancer Res 2006; 66(2): 1089-95)

1 January 2013 in Journal of Burn Care & Research
Verified
Journal Article
Open access
PDF file
JWJames F. Williams
James F. Williams
BKBooker T. King
Booker T. King
JAJames Aden
James Aden
MSMaria Serio-Melvin
Maria Serio-Melvin
Kevin Kien Hoa ChungKevin Kien Hoa Chung
Kevin Kien Hoa Chung
Leopoldo C. CancioLeopoldo C. Cancio
Leopoldo C. Cancio
Accurate burn estimation affects the use of burn resuscitation formulas and treatment strategies, and thus can affect patient outcomes. The objective

1 March 2015 in Military Medicine
Verified
Journal Article
Open access
CHCarmen Hinojosa-Laborde
Carmen Hinojosa-Laborde
JAJames Aden
James Aden
KGKathleen A. Goei
Kathleen A. Goei
Victor A. ConvertinoVictor A. Convertino
Victor A. Convertino
Lower body negative pressure (LBNP) simulates hemorrhage, and tolerance to LBNP (time to presyncope [TTP]) is indicative of tolerance to blood loss. The purpose of this study was to predict TTP based on demographic characteristics (sex, age, height, and body mass index) and physiological variables (heart rate [HR], systolic arterial pressure, diastolic arterial pressure [DAP], pulse pressure, stroke volume, total peripheral resistance [TPR], and baroreflex sensitivity [BRS]) at baseline, and during 2 levels of LBNP (-15, -30 mm Hg). Multiple linear regression analysis was used to create a model to predict TTP (range: 670 to 2516 seconds, n=187) based on demographic characteristics and physiological variables changes (Δ) from baseline to -30 mm Hg LBNP. The prediction model revealed that TTP (seconds)=1667.5+(5.1×Age)+(61.1×Sex)-(21.5×ΔHR)+(55.3×ΔDAP)-(88.2×ΔTPR)-(4.9×ΔBRS). Most significantly, our analysis demonstrated a lesser survival trajectory for females given the same rate and magnitude of hemorrhage compared to males. Young age and female sex are predictors of low tolerance to blood loss, and should be considered for early triage in the prehospital setting.

20 June 2023 in Journal of Burn Care & Research
Verified
Journal Article
Open access
PDF file
JRJulie A Rizzo
Julie A Rizzo
ECElsa C Coates
Elsa C Coates
MSMaria L Serio-Melvin
Maria L Serio-Melvin
JAJames Aden
James Aden
JSJonathan D Stallings
Jonathan D Stallings
JSJose Salinas
Jose Salinas
Initial fluid infusion rates for resuscitation of burn injuries typically use formulas based on patient weight and total body surface area (TBSA) burned. However, the impact of this rate on overall resuscitation volumes and outcomes have not been extensively studied. The purpose of this study was to determine the impact of initial fluid rates on 24-hour volumes and outcomes using the Burn Navigator (BN). The BN database is composed of 300 patients with ≥20% TBSA, >40 kg that were resuscitated utilizing the BN. Four study arms were analyzed based on the initial formula—2 ml/kg/TBSA, 3 ml/kg/TBSA, 4 ml/kg/TBSA or the Rule of Ten. Total fluids infused at 24 hours after admission were compared as well as resuscitation-related outcomes. A total of 296 patients were eligible for analysis. Higher starting rates (4 ml/kg/TBSA) resulted in significantly higher volumes at 24 hours (5.2 ± 2.2 ml/kg/TBSA) than lower rates (2 ml/kg/TBSA resulted in 3.9 ± 1.4 ml/kg/TBSA). No shock was observed in the high resuscitation cohort, whereas the lowest starting rate exhibited a 12% incidence, lower than both the Rule of Ten and 3 ml/kg/TBSA arms. There was no difference in 7-day mortality across groups. Higher initial fluid rates resulted in higher 24-hour fluid volumes. The choice of 2ml/kg/TBSA as initial rate did not result in increased mortality or more complications. An initial rate of 2ml/kg/TBSA is a safe strategy.

1 January 2016 in Journal of Special Operations Medicine
Verified
Journal Article
Closed access
RGRudy Gibson
Rudy Gibson
JAJames Aden
James Aden
MDMichael A Dubick
Michael A Dubick
JKJohn F Kragh
John F Kragh
Journal of Special Operations Medicine Featured Articles for Summer 2016. Volume 16 Issue 2.

1 January 2013 in Journal of Special Operations Medicine
Verified
Journal Article
Closed access
JKJohn F Kragh
John F Kragh
MDMichael A Dubick
Michael A Dubick
JAJames Aden
James Aden
AMAnne L McKeague
Anne L McKeague
TRTodd E Rasmussen
Todd E Rasmussen
LBLorne H Blackbourne
Lorne H Blackbourne
Journal of Special Operations Medicine Featured Articles for Winter 2013. Volume 13 Issue 4.